Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer Patients

Study Overview
=================
Brief Summary
-----------------
Studies have shown that tumor specific amplitude-modulated frequencies of radiofrequency electromagnetic fields that is associated with biofeedback upon exposure to in cancer patients. However, such discovery in other cancer patients are rare. And whether tumor specific frequencies can be found in Asian cancer patients remains unclear. The purpose of this study is to detect the tumor specific frequencies of Asian cancer patients in vivo.

Detailed Description
-----------------
The measurements were safety guaranteed and were conducted in hospital. Before detecting, the patient will be already diagnosed with cancer. The doctor and the operator are responsible for the detecting. When cancer patients are exposure to the RF electromagnetic fields, the radial pulse amplitude, blood pressure, skin electrical resistance and breath will be monitored. Biofeedback parameters will be recorded at different modulation frequencies and analyzed in order to find the variation and tumor specific frequencies.

Official Title
-----------------
Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer Patients In Vivo

Conditions
-----------------
Neoplasms

Intervention / Treatment
-----------------
* Device: Low intensity amplitude-modulated RF EMFs


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Clinical diagnosis of cancer Disease Exclusion Criteria: other patients
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| cancer patients<br>Low intensity amplitude-modulated RF EMFs | Device: Low intensity amplitude-modulated RF EMFs<br>* Low intensity amplitude-modulated radiofrequency electromagnetic fields,the carrier frequency is 27.12MHz with a power of about 100mW<br>* Other names: Low intensity AM RF EMFs;|
| healthy participators<br>Low intensity amplitude-modulated RF EMFs | Device: Low intensity amplitude-modulated RF EMFs<br>* Low intensity amplitude-modulated radiofrequency electromagnetic fields,the carrier frequency is 27.12MHz with a power of about 100mW<br>* Other names: Low intensity AM RF EMFs;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Biofeedback response of cancer patients at the exposure of Low intensity amplitude-modulated radiofrequency electromagnetic fields |  | within 20 min of exposure | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Representation of autonomous response during the exposure of tumor specific frequencies modutated RF eletromagnetic fields |  | within 20 min of exposure | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
RF EMF, In Vivo, tumor specific frequencies